BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of DKK 591.96 million. The enterprise value is 553.34 million.

Market Cap	591.96M
Enterprise Value	553.34M

Important Dates

The last earnings date was Friday, August 15, 2025.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

BioPorto has 454.66 million shares outstanding. The number of shares has increased by 12.64% in one year.

Current Share Class	454.66M
Shares Outstanding	454.66M
Shares Change (YoY)	+12.64%
Shares Change (QoQ)	+5.11%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	0.31%
Float	452.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.52
PB Ratio	10.35
P/TBV Ratio	10.38
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.56
EV / Sales	15.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.38

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.16.

Current Ratio	2.87
Quick Ratio	2.56
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	-0.11
Interest Coverage	-41.18

Financial Efficiency

Return on equity (ROE) is -104.13% and return on invested capital (ROIC) is -62.60%.

Return on Equity (ROE)	-104.13%
Return on Assets (ROA)	-50.43%
Return on Invested Capital (ROIC)	-62.60%
Return on Capital Employed (ROCE)	-140.52%
Revenue Per Employee	746,667
Profits Per Employee	-1.76M
Employee Count	48
Asset Turnover	0.33
Inventory Turnover	2.96

Taxes

Income Tax	-7.97M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.20% in the last 52 weeks. The beta is 0.93, so BioPorto's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-46.20%
50-Day Moving Average	1.37
200-Day Moving Average	1.51
Relative Strength Index (RSI)	42.03
Average Volume (20 Days)	314,169

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPorto had revenue of DKK 35.84 million and -84.37 million in losses. Loss per share was -0.19.

Revenue	35.84M
Gross Profit	22.35M
Operating Income	-88.59M
Pretax Income	-92.34M
Net Income	-84.37M
EBITDA	-87.80M
EBIT	-88.59M
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 47.77 million in cash and 9.14 million in debt, giving a net cash position of 38.62 million or 0.08 per share.

Cash & Cash Equivalents	47.77M
Total Debt	9.14M
Net Cash	38.62M
Net Cash Per Share	0.08
Equity (Book Value)	57.22M
Book Value Per Share	0.13
Working Capital	46.78M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -84.96 million and capital expenditures -1.72 million, giving a free cash flow of -86.67 million.

Operating Cash Flow	-84.96M
Capital Expenditures	-1.72M
Free Cash Flow	-86.67M
FCF Per Share	-0.19

Full Cash Flow Statement

Margins

Gross margin is 62.35%, with operating and profit margins of -247.17% and -235.40%.

Gross Margin	62.35%
Operating Margin	-247.17%
Pretax Margin	-257.65%
Profit Margin	-235.40%
EBITDA Margin	-244.97%
EBIT Margin	-247.17%
FCF Margin	n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.64%
Shareholder Yield	n/a
Earnings Yield	-14.25%
FCF Yield	-14.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1